Chemotherapy Induced Peripheral Neuropathy Market Growth, Trends, Industry Analysis and Forecast – 2028

The chemotherapy induced peripheral neuropathy market is expected to register a CAGR of 5.4% from 2022 to 2028.

Chemotherapy-induced peripheral neuropathy is one of the most frequent side effects caused by antineoplastic agents. Clinically, it is a mostly sensory neuropathy that may be accompanied by motor and autonomic changes of varying intensity and duration. Due to its high prevalence among cancer patients, chemotherapy-induced peripheral neuropathy constitutes a major problem for both cancer patients and survivors as well as for their health care providers, especially because, at the moment, there is no single effective method of preventing it; moreover, the possibilities of treating this syndrome are limited.

Market Segmentation:

By Therapy

• Medications
• Surgery
• Transcutaneous Electrical Nerve Stimulation
• Others

Company Profiles

• Regenacy Pharmaceuticals, Inc.
• Asahi Kasei Pharma Corporation
• Novaremed
• Makscientific, Llc
• Wex Pharmaceuticals Inc.
• Sova Pharmaceuticals, Inc.
• Kineta, Inc.
• Aptinyx Inc.
• Apexian Pharmaceuticals, Inc.
• Winsantor, Inc.

 Recent Developments

• Market Overview and growth analysis
• Import and Export Overview
• Volume Analysis
• Current Market Trends and Future Outlook
• Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume

o Latin America Market Size and/or Volume

o Europe Market Size and/or Volume

o Asia-Pacific Market Size and/or Volume

o Rest of the world Market Size and/or Volume

The report covers the following objectives:

• Proliferation and maturation of trade in the Chemotherapy Induced Peripheral Neuropathy Market .
• The market share of the Transport Media Market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Chemotherapy Induced Peripheral Neuropathy Market .
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Chemotherapy Induced Peripheral Neuropathy Market .